Abstract:Objective To investigate the correlation of serum soluble receptor for advanced glycation end products (sRAGE) with severity degree and stress hyperglycemia in severe pneumonia patients. Methods From 2016.06 to 2019.05, 100 patients with severe pneumonia, 100 patients with pneumonia and 100 healthy cases in our hospital were enrolled into the study. The serum sRAGE, tumor necrosis α (TNF-α), interleukin-6 (IL-6), hypersensitivity C reactive protein (hs-CRP), advanced glycation end products (AGEs) levels of all subjects were detected and compared. According to the fasting plasma glucose (FPG), 100 patients with severe pneumonia were divided into stress hyperglycemia group (FPG ≥ 7.0 mmol/L) and non-stress hyperglycemia group (FPG < 7.0 mmol/ L). Unvariate and multivariate linear regression analysis were used to analyze the influence factors of sRAGE in severe pneumonia patients. Results The serum sRAGE levels in severe pneumonia patients were higher than healthy cases and pneumonia patients (P < 0.05). And the serum sRAGE levels in stress hyperglycemia group were higher than that in non-stress hyperglycemia group (P < 0.05). Multivariate regression model analysis showed APACHEⅡ score [Ol ^ R = 2.295 (95% CI: 1.877, 3.241)], MODS score [Ol ^ R = 3.315 (95% CI: 2.186, 5.673)], serum AGEs (Ol ^ R = 1.271 (95% CI: 1.026, 1.573)], serum sRAGE [Ol ^ R = 1.328 (95% CI: 1.105, 1.792)] were the independent influence factors of stress hyperglycemia in severe pneumonia patients (P < 0.05). Conclusions The serum sRAGE levels in severe pneumonia patients increase, especially in stress hyperglycemia patients, which could reflect the severity degree of pneumonia and stress hyperglycemia.